CSIMarket
 
Guided Therapeutics Inc   (GTHP)
 
Price: $0.2000 $-0.04 -15.966%
Day's High: $0.25 Week Perf: -11.11 %
Day's Low: $ 0.20 30 Day Perf: -31.03 %
Volume (M): 7,800 52 Wk High: $ 0.54
Volume (M$): $ 0 52 Wk Avg: $0.28
Open: $0.25 52 Wk Low: $0.15



 Market Capitalization (Millions $) 19
 Shares Outstanding (Millions) 97
 Employees 3
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -4
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Guided Therapeutics Inc is a medical device company that specializes in the development and commercialization of non-invasive diagnostic devices. The company's flagship product is the LuViva Advanced Cervical Scan, which is designed to detect cervical disease and precancerous conditions in women.

Guided Therapeutics' LuViva technology utilizes a non-invasive method that combines spectroscopy and advanced optics to provide immediate results and improve the accuracy of cervical disease detection. The device can distinguish between normal and abnormal cervical tissue, enabling healthcare providers to make timely and educated decisions regarding patient care.

The company is dedicated to improving women's health and reducing the number of unnecessary biopsies and procedures associated with cervical disease. By providing a non-invasive, quick, and accurate diagnostic solution, Guided Therapeutics aims to transform the way cervical disease is detected and managed.

Guided Therapeutics Inc has received regulatory approvals for its product in various countries and continues to expand its commercial reach globally. The company also actively engages in research and development to enhance its existing technology and explore new applications in the field of non-invasive diagnostics.


   Company Address: 5835 Peachtree Corners East Peachtree Corners 30092
   Company Phone Number: 242-8723   Stock Exchange / Ticker: GTHP


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
EDAP        6.03% 
ESTA        5.17% 
IRIX   -1.41%    
LNSR        3.37% 
MDT        3.22% 
OSUR   -3.33%    
• View Complete Report
   



Business Update

Guided Therapeutics Eyes New Markets Amid Ongoing Financial Challenges,

Published Tue, Dec 10 2024 5:47 PM UTC

In a significant strategic move, Guided Therapeutics, Inc. the developer of the LuViva Advanced Cervical Scan, has secured a major order from an Indonesian distribution partner, marking a pivotal moment for the company. The order includes four LuViva devices along with 1,200 single-use disposables, which are set to be delivered in the first quarter of 2025. This initial ship...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 29.70
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio -
Working Capital Ratio 0.09
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.05 $
Revenues (TTM) 0.01 $
Cash Flow (TTM) 0 $
Cash -
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -1,190,333
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.